• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直接从血培养物中快速测定产碳青霉烯酶肠杆菌科细菌对头孢他啶/阿维巴坦的敏感性:EUCAST纸片扩散RAST与直接Etest® RAST的比较评估

Rapid determination of ceftazidime/avibactam susceptibility of carbapenemase-producing Enterobacterales directly from blood cultures: a comparative evaluation of EUCAST disc diffusion RAST and direct Etest® RAST.

作者信息

Bianco Gabriele, Boattini Matteo, Comini Sara, Iannaccone Marco, Cavallo Rossana, Costa Cristina

机构信息

Microbiology and Virology Unit, University Hospital Città della Salute e della Scienza di Torino, Turin, Italy.

Department of Public Health and Paediatrics, University of Turin, Turin, Italy.

出版信息

J Antimicrob Chemother. 2022 May 29;77(6):1670-1675. doi: 10.1093/jac/dkac092.

DOI:10.1093/jac/dkac092
PMID:35325155
Abstract

OBJECTIVES

To evaluate the performance of two rapid antimicrobial susceptibility testing (RAST) methods to determine ceftazidime/avibactam susceptibility directly from blood cultures (BCs).

METHODS

A total of 246 Escherichia coli or Klebsiella pneumoniae isolates were tested for ceftazidime/avibactam susceptibility directly from BC bottles using EUCAST RAST and Etest® RAST. Results obtained after 4, 6 and 8 h of incubation were compared with those obtained by reference broth microdilution on pure overnight subcultures.

RESULTS

In total, the proportion of readable zones after 4 h of incubation was 96.7% and reached 100% after 6 and 8 h of incubation. EUCAST RAST yielded >98% of categorical agreement (CA) with all reading times. Major error (ME) and very major error (VME) rates were inferior to 3%, for each of the reading times. The proportion of results in the area of technical uncertainty (ATU) was almost similar (3.8%-4.1%) at the different reading times. DET-RAST yielded 97.5%, 98% and 99.6% of CA with readings at 4, 6 and 8 h, respectively. One (0.6%) ME was observed at each reading time, whereas five (5.9%) and four (4.5%) VMEs were observed analysing readings at 4 and 6 h, respectively. No VME was observed with readings at 8 h.

CONCLUSIONS

EUCAST RAST was accurate to determine ceftazidime/avibactam susceptibility of carbapenemase-producing K. pneumoniae and E. coli directly from BC bottles. DET-RAST has the advantage of determining MIC values and avoiding ATU results but showed to be an accurate method only with reading at 8 h.

摘要

目的

评估两种快速抗菌药物敏感性试验(RAST)方法直接从血培养(BC)中确定头孢他啶/阿维巴坦敏感性的性能。

方法

使用欧盟CAST RAST和Etest® RAST直接从BC瓶中对总共246株大肠埃希菌或肺炎克雷伯菌分离株进行头孢他啶/阿维巴坦敏感性测试。将孵育4、6和8小时后获得的结果与通过参考肉汤微量稀释法对过夜纯传代培养物获得的结果进行比较。

结果

总体而言,孵育4小时后可读区域的比例为96.7%,孵育6和8小时后达到100%。在所有读取时间,欧盟CAST RAST的分类一致性(CA)均>98%。每个读取时间的主要误差(ME)和极主要误差(VME)率均低于3%。在不同读取时间,技术不确定区域(ATU)的结果比例几乎相似(3.8%-4.1%)。DET-RAST在4、6和8小时读取时的CA分别为97.5%、98%和99.6%。在每个读取时间观察到1例(0.6%)ME,而在分析4和6小时读取结果时分别观察到5例(5.9%)和4例(4.5%)VME。在8小时读取时未观察到VME。

结论

欧盟CAST RAST可准确直接从BC瓶中确定产碳青霉烯酶肺炎克雷伯菌和大肠埃希菌对头孢他啶/阿维巴坦的敏感性。DET-RAST具有确定最低抑菌浓度(MIC)值并避免ATU结果的优势,但仅在8小时读取时才是一种准确的方法。

相似文献

1
Rapid determination of ceftazidime/avibactam susceptibility of carbapenemase-producing Enterobacterales directly from blood cultures: a comparative evaluation of EUCAST disc diffusion RAST and direct Etest® RAST.直接从血培养物中快速测定产碳青霉烯酶肠杆菌科细菌对头孢他啶/阿维巴坦的敏感性:EUCAST纸片扩散RAST与直接Etest® RAST的比较评估
J Antimicrob Chemother. 2022 May 29;77(6):1670-1675. doi: 10.1093/jac/dkac092.
2
Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against Clinical Isolates.头孢他啶-阿维巴坦 30/20μg 药敏纸片法、Etest 法与肉汤微量稀释法检测临床分离株结果比较
Microbiol Spectr. 2022 Feb 23;10(1):e0109221. doi: 10.1128/spectrum.01092-21. Epub 2022 Jan 12.
3
Fully Automated EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) from Positive Blood Cultures: Diagnostic Accuracy and Implementation.全自动 EUCAST 快速药敏试验(RAST)从阳性血培养物:诊断准确性和实施。
J Clin Microbiol. 2022 Oct 19;60(10):e0089822. doi: 10.1128/jcm.00898-22. Epub 2022 Sep 29.
4
Rapid antimicrobial susceptibility of Enterobacteriaceae by disk diffusion directly from blood culture bottles using the EUCAST RAST breakpoints.使用 EUCAST RAST 折点,通过直接从血培养瓶进行的纸片扩散法快速检测肠杆菌科的抗菌药物敏感性。
J Glob Antimicrob Resist. 2020 Sep;22:637-642. doi: 10.1016/j.jgar.2020.05.015. Epub 2020 Jun 5.
5
[Evaluation of EUCAST Direct Rapid Antimicrobial Susceptibility Test Method in Blood Culture Bottles with Positive Signal].[欧盟CAST直接快速药敏试验方法在有阳性信号血培养瓶中的评估]
Mikrobiyol Bul. 2021 Oct;55(4):626-634. doi: 10.5578/mb.20219713.
6
Evaluation of the feasibility of EUCAST RAST using antimicrobial disks available in Japan.评估使用日本现有的抗菌药敏纸片进行 EUCAST RAST 的可行性。
J Infect Chemother. 2023 Oct;29(10):978-984. doi: 10.1016/j.jiac.2023.06.016. Epub 2023 Jul 1.
7
Evaluation of the Etest and disk diffusion method for detection of the activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa in China.评估 Etest 和纸片扩散法检测头孢他啶-阿维巴坦对中国肠杆菌科和铜绿假单胞菌的活性。
BMC Microbiol. 2020 Jun 29;20(1):187. doi: 10.1186/s12866-020-01870-z.
8
Evaluation of EUCAST rapid antimicrobial susceptibility testing (RAST) directly from blood culture bottles.直接从血培养瓶中评估欧洲临床微生物和感染性疾病学会(EUCAST)快速抗菌药物敏感性试验(RAST)。
Eur J Clin Microbiol Infect Dis. 2020 May;39(5):993-998. doi: 10.1007/s10096-020-03815-w. Epub 2020 Jan 18.
9
Establishing breakpoints for amoxicillin/clavulanate and ampicillin/sulbactam for rapid antimicrobial susceptibility testing directly from positive blood culture bottles.建立阿莫西林/克拉维酸和氨苄西林/舒巴坦的折点,以便直接从阳性血培养瓶中进行快速抗菌药物敏感性测试。
J Med Microbiol. 2023 Mar;72(3). doi: 10.1099/jmm.0.001672.
10
Development of EUCAST zone diameter breakpoints and quality control criteria for ceftazidime-avibactam 10-4 μg.EUCAST 折点和头孢他啶-阿维巴坦 10-4μg 质量控制标准的制定。
Eur J Clin Microbiol Infect Dis. 2018 Jun;37(6):1047-1053. doi: 10.1007/s10096-018-3215-9. Epub 2018 Mar 30.

引用本文的文献

1
Evaluation of EUCAST Rapid Antimicrobial Susceptibility Testing for Gram-Negative Bacteria Directly from Positive Blood Cultures.直接从阳性血培养物中对革兰氏阴性菌进行欧盟CAST快速药敏试验的评估。
Infect Drug Resist. 2025 Jul 23;18:3579-3590. doi: 10.2147/IDR.S514981. eCollection 2025.
2
Clinical and Microbiological characteristics of patients with ceftazidime/avibactam-resistant Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae strains.产头孢他啶/阿维巴坦耐药肺炎克雷伯菌碳青霉烯酶(KPC)的肺炎克雷伯菌菌株感染患者的临床和微生物学特征
Ann Clin Microbiol Antimicrob. 2025 Apr 18;24(1):26. doi: 10.1186/s12941-025-00797-5.
3
Mortality-related risk factors of carbapenem-resistant Enterobacteriaceae infection with focus on antimicrobial regimens optimization: a real-world retrospective study in China.
耐碳青霉烯类肠杆菌科细菌感染的死亡相关危险因素及抗菌方案优化:一项中国的真实世界回顾性研究
BMC Infect Dis. 2025 Jan 23;25(1):110. doi: 10.1186/s12879-025-10454-z.
4
In Vitro Susceptibility to Ceftazidime-Avibactam and Comparator Antimicrobial Agents of Carbapenem-Resistant Enterobacterales Isolates.耐碳青霉烯类肠杆菌科细菌分离株对头孢他啶-阿维巴坦及对照抗菌药物的体外敏感性
Microorganisms. 2023 Aug 25;11(9):2158. doi: 10.3390/microorganisms11092158.
5
Multicentre Evaluation of the EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) Extending Analysis to 16-20 Hours Reading Time.欧盟CAST快速药敏试验(RAST)多中心评估:将分析时间延长至16 - 20小时读数时间
Antibiotics (Basel). 2022 Oct 13;11(10):1404. doi: 10.3390/antibiotics11101404.
6
C/MIC > 4: A Potential Instrument to Predict the Efficacy of Meropenem.碳青霉烯类最低抑菌浓度与最低杀菌浓度比值>4:一种预测美罗培南疗效的潜在指标
Antibiotics (Basel). 2022 May 16;11(5):670. doi: 10.3390/antibiotics11050670.